Arformoterol/Budesonide for COVID-19

Clinical trial NCT05055414 · UNKNOWN

Trial details

NCT number: NCT05055414
Sponsor: Korea United Pharm. Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Infection

Start date: 2021-11-01
Primary completion: 2022-10-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.